NCT03658343View on ClinicalTrials.gov

T2* MRI Analysis for Sarcoma

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

September 18, 2018

Primary Completion Date

February 25, 2022

Study Completion Date

February 25, 2022

Conditions
RadiotherapyMagnetic Resonance ImagingSarcoma
Interventions
DIAGNOSTIC_TEST

T2* Imaging

T2\* imaging sequences for MRI

Trial Locations (1)

52242

Holden Comprehensive Cancer Center, Iowa City

Sponsors

Lead Sponsor

Bryan Allen
All Listed Sponsors
collaborator

Holden Comprehensive Cancer Center

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Bryan Allen

OTHER